# OnCo record nrg-br002 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nrg-br002/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nrg-br002", "NCT02364557" ;
  schema:name "NRG-BR002: metastasis-directed ablation in limited metastatic breast cancer"@en ;
  schema:alternateName "NRG BR002"@en ;
  schema:description "NRG-BR002 did not meet its progression endpoint for added metastasis-directed ablation in a selected breast-cancer population. The planned phase 3 portion did not proceed."@en ;
  schema:url <https://onco.cc/trials/nrg-br002/> ;
  schema:dateModified "2026-11-09"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02364557>, <https://pubmed.ncbi.nlm.nih.gov/42842849/> ;
  onco:status "negative" ;
  onco:tag "education-audit", "local-treatment" ;
  onco:phase "2/3" ;
  schema:startDate "2014-12-24" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:technologies <https://onco.cc/technologies/sbrt/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nrg-br002-jco-2026/> .
